Abstract
Mammalian artificial chromosomes derived from native chromosomes have been applied to biomedical research and development by generating cell sources and transchromosomic (Tc) animals. Human artificial chromosome (HAC) is a precedent chromosomal vector which achieved generation of valuable humanized animal models for fully human antibody production and human pharmacokinetics. While humanized Tc animals created by HAC vector have attained significant contributions, there was a potential issue to be addressed regarding stability in mouse tissues, especially highly proliferating hematopoietic cells. Mouse artificial chromosome (MAC) vectors derived from native mouse chromosome 11 demonstrated improved stability, and they were utilized for humanized Tc mouse production as a standard vector. In mouse, however, stability of MAC vector derived from native mouse chromosome other than mouse chromosome 11 remains to be evaluated. To clarify the potential of mouse centromeres in the additional chromosomes, we constructed a new MAC vector from native mouse chromosome 10 to evaluate the stability in Tc mice. The new MAC vector was transmitted through germline and stably maintained in the mouse tissues without any apparent abnormalities. Through this study, the potential of additional mouse centromere was demonstrated for Tc mouse production, and new MAC is expected to be used for various applications.
Similar content being viewed by others
Introduction
Human artificial chromosome (HAC) vectors derived from native human chromosomes, independently and stably maintained without disrupting host chromosomes, have capacities to carry desired copy number of genes via recombination sites, and transfer a large quantity of Mb-sized genes1. Taking these advantages over conventional vectors, transchromosomic (Tc) mice into which arbitrary genes were introduced via the HAC vectors, have been generated2,3. However, in an attempt to create a mouse model, the HAC vectors have demonstrated a variable retention rate in tissues of mouse individuals, and that stability is particularly low in hematopoietic cells with high proliferation4. To address this issue, we established a chromosome transfer- and recombinase-mediated genomic transfer (CT-RMGT) method that maintains an arbitrary human chromosomal region at the chromosome end of the mouse host via chromosome engineering technologies5. As a result, although stability was ensured, the method was labor-intensive and time-consuming, which was a barrier to constantly generate the mouse models.
Under these circumstances, a strategy to design a stable mouse artificial chromosome (MAC) vector was conceived through construction of a MAC vector from native mouse chromosome 11 based on the hypothesis that the centromere from own species contributes to high stability (hereinafter referred to as 11MAC)4. As in the construction of HAC vectors, the MAC vectors have a structure in which endogenous gene region was deleted by telomere truncation, and the recombination acceptor site capable of gene loading and translocation cloning was inserted. The MAC vectors have the same advantages as the HAC vectors, and additionally have been shown to be uniformly and stably maintained in the mouse tissues including hematopoietic cells4. Several Tc mouse models for prediction of human pharmacokinetics and aneuploidy syndrome have been generated by using the 11MAC vectors6,7,8,9,10. Furthermore, the 11MAC was found to be stable in rat tissues by generating Tc rat models for human pharmacokinetics8.
Importantly, the 11MAC vector is stably maintained in the tissues of Tc mouse as the 41st chromosome. In the Tc mice, two pairs of mouse chromosome 11 with endogenous genes and additional mouse chromosome 11 centromere with no genes are held. In particular, it has been revealed that the 11MAC vector itself does not affect development and homeostasis of the mouse3. However, it remains unclear whether MAC vector derived from native mouse chromosome other than mouse chromosome 11 are similarly and stably maintained in the mouse tissues as the 41st chromosome. Further examples are needed to clarify the original hypothesis.
To investigate this, a new MAC with different centromere from other chromosomes excluding native mouse chromosome 11 was required. Current understandings of mouse chromosomes suggest mouse centromere on each chromosome is composed of different copy number of core centromere (minor: 120 bp) satellite and pericentromeric (major: 234 bp) satellite repeat except Y chromosome as different signal intensities or colors were observed on each chromosome in quantitative fluorescence in situ hybridization (Q-FISH) or multicolor FISH (mFISH) images of mouse embryonic fibroblast (MEF) or mouse embryonic stem (mES) cells4,11,12,13. Additionally, the previous analysis of composition of genetic materials on chromosomes suggested that mouse chromosome 10 was more recently reorganized based on evolutionary studies14,15. Therefore, considering the potential differences in composition of centromere sequence and chromosome evolution, we selected mouse chromosome 10 to construct new MAC. In addition, construction of MAC vector needed the native mouse chromosome tagged with drug selection marker to transfer the chromosome to other cells for efficient modification with conventional chromosome engineering techniques.
In this study, to elucidate the above, we constructed a new MAC vector from native mouse chromosome 10 (10MAC), and produced Tc mice carrying the 10MAC. The 10MAC was constructed through the whole cell fusion and chromosome transfer with microcell-mediated chromosome transfer (MMCT) to the cells for chromosome modification. Constructed 10MAC1 and other divergent vectors were transferred to CHO cells for testing the gene loading capacity as gene delivery vectors. The 10MAC1 was further transferred to mouse embryonic stem cells to produce the Tc mice. Retention and structure of mouse chromosome 10 and 10MAC vectors in the host cells and mice were visibly analyzed by FISH. We also confirmed that the 10MAC1 can be stably retained in the mouse tissues with GFP monitoring system and does not affect the development and homeostasis of the mouse. Taken together, we here demonstrated the generation of a functional MAC vector underived from mouse chromosome 11, and verified the capability of 10MAC vectors for generation of Tc mice.
Results
Generation of a 10MAC
We performed the following experiments to generate MAC from native mouse chromosome 10 by chromosome engineering (Fig. 1). Mouse A9 cells are good donors for MMCT owing to the property of high micronuclei formation induced by colcemid treatment. Therefore, MEFs, in which endogenous mouse chromosome 10 (mChr.10) was tagged with NeoR gene (mChr.10-NeoR), were fused with mouse A9 cells carrying Bsd gene. We obtained mouse A9-like whole cell hybrids resistant to both G418 and Blasticidin S. Then, the mChr.10-NeoR was transferred from the hybrid cells to homologous recombination-proficient chicken DT40 cells via MMCT. DT40 cells are useful host cells for efficient chromosome modification. FISH analysis confirmed that the mChr.10-NeoR was independently and stably maintained in DT40 hybrid cells (Fig. 2A).
To truncate endogenous gene-coding region of mChr.10, pericentromeric region was targeted by artificial telomere seeding technique (Fig. 2B). The targeting vector carrying the puromycin resistant gene was introduced into DT40 mChr.10-NeoR by electroporation. As a result of screening drug-resistant clones by PCR and FISH analyses, deletion of a region distal to the target sequence of mChr.10 (hereafter referred as 10MAC) was confirmed in 4 out of 266 clones (DT40 10MAC) (Fig. 2C). In the obtained DT40 10MAC clones, deletion of the endogenous gene-coding region and NeoR gene resulted in an empty artificial chromosome composed of centromere and telomeres.
Construction of MAC capable of gene loading by recombination system
Consistent with the past artificial vectors we designed, we attempted to construct an artificial chromosome vector capable of carrying desired genes via Cre/loxP recombination system. First, a 10MAC vector carrying CAG-EGFP flanked by insulators, NeoR gene and loxP-3’HPRT was constructed (Fig. 2D). Regarding the gene loading on the 10MAC vectors and selection system, we utilized HPRT gene reconstitution system with HAT (hypoxanthine, aminopterin and thymidine) selection in CHO hprt−/− cells16,17. First half unit is PGK promoter-5’UTR-HPRT exon 1–2-splice donor-intron-loxP (5’HPRT-loxP), and another unit is loxP-intron-splice acceptor-HPRT exon 3–9-poly A signal (loxP-3’HPRT). To survive and proliferate, CHO hprt−/− cells required HPRT gene, hypoxanthine and thymidine via HPRT-contributed salvage pathway under the presence of de novo nucleoside biosynthesis pathway inhibitor, aminopterin. If successful gene loading occurred by Cre/loxP system, concatenation of 5’HPRT-loxP and loxP-3’HPRT on either 10MAC or gene loading vector/donor chromosome would result in HPRT expression, which conferred HAT resistance to CHO hprt−/− cells for drug screening. After electroporation of targeting construct to DT40 10MAC, drug selection was performed with G418, and 24 clones, positive for EGFP fluorescence and drug resistance, were randomly selected for further screening (Fig. 2E). Eight out of 24 clones were PCR positive, and as demonstrated by FISH analysis, in all 8 clones, a signal indicating the presence of the loaded unit was confirmed on the MAC maintained independently of the host chromosome (DT40 10MAC1) (Fig. 2F).
Next, 10MAC vector carrying NeoR gene and 5’HPRT-loxP was constructed (Fig. 3A). A targeting construct was introduced into DT40 10MAC by electroporation, and 23 clones were randomly selected from the obtained drug resistant clones. Twenty one out of 23 clones were PCR positive. Five clones were selected from PCR positive clones and FISH analysis was performed. We confirmed the presence of the platform inserted on the 10MAC that was maintained independently in all clones (DT40 10MAC2) (Fig. 3B).
Furthermore, the 10MAC which contains CAG-EGFP flanked by insulators, NeoR gene and 5’HPRT-loxP was constructed (Fig. 3C). A targeting construct was introduced into DT40 10MAC, and 24 EGFP fluorescence positive and drug resistant clones were randomly selected (Fig. 3D). PCR analysis was performed, and 23 clones were confirmed to be PCR positive. Among them, 5 clones were selected and analyzed by FISH. FISH analysis revealed that the expected targeting occurred on the 10MAC for all clones (DT40 10MAC3) (Fig. 3E). As a result, three types of 10MAC vectors with different platforms were constructed (Supplementary Fig. S1).
Transfer of 10MAC1 to CHO hprt−/− cell line and verification of site-specific recombination
The loxP-3’HPRT unit on the 10MAC1 is utilized for the reconstitution of HPRT gene and enables HAT selection when the desired gene with 5’HPRT-loxP unit is loaded via Cre/loxP system. Therefore, 10MAC1 was transferred from DT40 to CHO hprt−/−, which is a Hprt gene-deficient cell line, by MMCT. Six clones of EGFP fluorescence positive and G418 resistant CHO hybrids were obtained (Fig. 4A). Although all clones were positive for PCR analysis, FISH analysis confirmed that one clone retained one copy of 10MAC1 independent of the host chromosome (CHO 10MAC1) (Fig. 4B). To evaluate whether the gene loading system functions on the 10MAC1, a plasmid carrying the 5’HPRT-loxP unit and Cre expression vector were co-transfected into CHO 10MAC1. PCR analysis of 24 randomly selected drug resistant clones revealed that all of them were positive for recombination junction PCR, which indicated that the system worked (Supplementary Table S2). Therefore, it was shown that the constructed 10MAC1 can be monitored by EGFP and gene loading can be performed efficiently.
Transfer of 10MAC2 and 10MAC3 to CHO hprt−/− cells and verification of gene loading
Following the strategy used to generate 10MAC1, 10MAC2 and 10MAC3 were transferred from DT40 cells to CHO hprt−/− cells by MMCT. Regarding the 10MAC2, 11 out of 12 drug-resistant CHO hybrids were PCR positive. FISH analysis was performed on 6 randomly selected clones, and it was confirmed that 3 clones maintained one copy of the 10MAC2 independent from the host chromosome (Fig. 4C). For the 10MAC3, 9 out of 10 clones of EGFP fluorescence positive and drug resistant CHO hybrids were PCR positive (Fig. 4D). FISH analysis revealed that 2 out of 6 clones were desired clones carrying a single copy of the 10MAC3 independent of the host (Fig. 4E). To check the stability of 10MAC vectors in the host cells from different species, Chinese hamster, the long-term culture under the presence or absence of selection drug was performed. The results obtained by FISH and FCM analyses showed that each MAC was relatively stable even under the absence of selection drug, and retention was almost 100% in the presence of selection drug (Supplementary Fig. S2).
For both 10MAC2 and 10MAC3, we verified whether gene-loaded clone could be obtained by HPRT reconstruction using the Cre/loxP system. A vector carrying loxP-3’HPRT and EGFP expression units and a vector containing loxP-3’HPRT and tdTomato expression units were transfected into CHO 10MAC2 and CHO 10MAC3, respectively, with the Cre expression vector (Fig. 5A,D and Supplementary Table S2). We obtained HAT-resistant clones positive for EGFP and tdTomato fluorescence (Fig. 5B,E). Furthermore, FISH analysis was performed to confirm the existence of on-board gene units on respective 10MAC vectors, excluding the possibility of random integration to host chromosome (Fig. 5C,F). Since signal of the loaded genes was detected on respective 10MACs, these results suggested that the gene-loading system worked as expected. Taken together, both 10MAC2 and 10MAC3 are capable of gene-loading using the Cre/loxP system.
Transfer of the 10MAC1 vector to mouse embryonic stem cells and Tc mice generation
To evaluate the stability of the 10MAC1 derived from native mouse chromosome 10 in mice, we attempted to generate Tc mouse carrying the 10MAC1. Chromosome transfer was performed by standard PEG-MMCT and retro-MMCT from CHO cells to mouse ES cells (39,XO) and drug-resistant and GFP-positive clones were selected for further analyses (Fig. 6A). Retro-MMCT is a highly efficient chromosome transfer method reported recently, which can reduce donor scale18. FISH analysis with the digoxigenin-labeled mouse minor satellite and biotin-labeled platform construct (pVGNLH1) probes showed that a single copy of 10MAC1 was independently maintained in mES hybrids (Fig. 6B). Among them, we selected clones with desired karyotype (40,XO, + 10MAC1) (TT2F 10MAC1). Then, we produced female chimeric mice with high coat-color chimerism by injecting TT2F 10MAC1 into eight-cell-stage embryo. These chimeric mice were crossed with wild-type mice to verify whether the 10MAC1 derived from native mouse chromosome 10 is transmitted through germline. Among the offsprings, GFP-positive mice with the 10MAC1 retention were obtained without any apparent abnormality (Fig. 6C). To confirm the independent maintenance of 10MAC1 from host chromosome, the metaphase spreads of lymphocytes in blood collected from Tc mice were analyzed. The 10MAC1 was single copy and independently maintained in host cells without integration (Fig. 6D). These results suggested that the 10MAC1 can be transmitted through germline and independently maintained without affecting the development of Tc mouse.
Retention rate of the 10MAC1 vector in mouse
To investigate whether 10MAC1 derived from native mouse chromosome 10 is stable in the mouse tissues in the identical manner as previously constructed 11MAC derived from native mouse chromosome 11, we analyzed Tc mice carrying 10MAC1 vector. The EGFP on the 10MAC1 was expressed in all tissues examined, which is comparable to 11MAC Tc mice (Fig. 6E).
Given the high rate of cellular turnover, hematopoietic cells from blood, bone marrow and spleen are optimal target cells to evaluate the stability of mammalian artificial chromosomes (ACs) in mouse. In previous report, HAC vector was relatively stable in various tissues except hematopoietic cells in Tc mice. In contrast, 11MAC derived from native mouse chromosome 11 is highly stable in all tissues examined including hematopoietic cells in Tc mice4. The degree of stability is thought to be more pronounced in the hematopoietic cells with rapid turnover. According to the data from several Tc mouse models generated by HAC and MAC vectors, the retention rate of mammalian ACs in the hematopoietic cells reflects those of mammalian ACs in the whole body.
Considering the reports mentioned above, in this study, we evaluated the stability of 10MAC1 in Tc mice by monitoring GFP-positive cells from blood, bone marrow and spleen by FCM analysis. The stability of 10MAC1 can be evaluated by monitoring GFP-positive cells because the 10MAC1 contains the GFP expression unit driven by constitutive active CAG promoter in common with the 11MAC1 as reported previously4. The retention rate of the 10MAC1 was high and uniform in B cells, CD4 and CD8 T cells from peripheral blood, bone marrow and spleen (89–94%) (Fig. 6F). The rates of GFP-positive cells with the 10MAC1 in lymphocytes from bone marrow and spleen were clearly higher than those with HAC (< 20%) and comparable to those with 11MAC1 (> 90%). The mice in minor population that showed lower retention rate of the 10MAC1 in the peripheral blood reflected the lower retention rates among different tissues (Supplementary Fig. S3 and S4). These results strongly support the high stability of the 10MAC1 and significant correlation of 10MAC1 retention rates between peripheral blood and different tissues.
The germline transmission efficiency and stability of 10MAC1 in lymphocytes was evaluated through generations. The germline transmission rates, i.e., 10MAC1-positive rates in offspring from male and female were 11.7% and 32.1–69.2%, respectively. As previously reported, the transmission rates of 11MAC1 to offspring were 30% from male and 50% from female19. This non-Mendelian segregation may be due to biological issues associated with fertilization or development, but not meiosis I and II stages. To maintain the strain, we utilized the mice with high GFP-positive rate in blood cells for crossing based on our empirical evidence that mice with high GFP-positive rate tend to give offspring with high GFP-positive rate. Regarding the stability, although some Tc mice showed lower retention rate, main population maintained high stability through generations (Supplementary Fig. S5). These results suggested that the 10MAC1 derived from native mouse chromosome 10 is highly stable in mice.
Discussion
In this study, we constructed a new MAC vector from native mouse chromosome 10. The 10MAC1 was transmitted through germline in mice and there was no apparent abnormality in Tc mice carrying 10MAC1 through generations. The assessment of stability by FCM analysis of lymphocyte subsets from each tissue clarified the high stability of 10MAC1 even in the hematopoietic cells with high proliferation. From the previous reports, because of the correlation between high proliferation and increased loss of mammalian ACs, the stability of ACs in lymphocyte subset is well established determinant factor reflecting their stability among various tissues in the host individuals4. Therefore, 10MAC1 is expected to be available for generating Tc mouse models. Considering the stability in mice, both 10MAC and 11MAC vectors are functionally comparable. The study also indicated that the MAC derived from native mouse chromosome other than mouse chromosome 11 is also highly stable in mice.
Further study is necessary to evaluate the different degrees of stability levels among native mouse centromeres by generating various MACs from other native chromosomes. To this end, multiple technological approaches through the combinations of the recent advancements in genome editing technology and chromosome transfer are expected to promote the research regarding the stability of centromeres in own species. In this analysis, as a starting point to clarify the potential of native mouse centromere for Tc mice production, the MAC vectors constructed herein can be utilized for various purposes including: (1) efficient gene loading system considering compatible constructs prepared previously, (2) cell resource production by transfer of new MACs with functional gene units, and (3) investigation on the compatibility of centromere function beyond species.
The 10MAC vectors described herein offer the following notable features with distinct aims. The 10MAC1 with loxP-3’HPRT is aimed at translocation cloning of desired chromosome fragments with 5’HPRT-loxP such as human native chromosome region to generate a humanized mouse model with gene cluster of Mb-sized gene16. The 10MAC2 is for loading general single vector or previously established simultaneous or sequential integration of multiple gene loading vectors (SIM system) which enable us to load multiple vectors sequentially or three vectors simultaneously each round16,20. The other gene loading system such as multi-integrase (MI) system also can be applied to 10MAC2 by inserting MI platform with four integrase and one recombinase acceptor sites21,22,23. The 10MAC3 is a chromosomal vector in which an EGFP monitor system is added to 10MAC2.
The 10MAC2 and 10MAC3 are expected to be utilized for not only generating mouse models but also establishing useful cell lines for material production and functional analysis comparable to those described by using 11MAC4. Several in vitro models have already been established; i.e., hepatoblastoma cell line, HepG2 carrying the 11MAC with the drug-metabolizing cytochrome P450 (CYP) enzymes for assessing drug metabolism and hepatotoxicity24,25,26, human colon adenocarcinoma cell line, Caco2 carrying the MAC with CYPs for prediction of the absorption and metabolism in the human intestine27, luminescent HepG2 with the MAC carrying luciferase reporter units for cytotoxicity assay26, immortalized mouse S3 cells carrying the 11MAC with Kidney injury molecule-1 (Kim-1) and Hprt reporter units for assessing nephrotoxicity28, and human mesenchymal stem cells (MSCs) carrying the MAC with osteocalcin (OC) reporter for monitoring osteogenic differentiation29. Additionally, recent work reported a double 11MAC-retaining cell based model wherein HepG2 cells with multiple CYPs and POR genes on one 11MAC and luminescence expression unit on another were generated for easy real-time monitoring system of hepatotoxicity by molecules30. Evidence of their applications with multiple copies also suggested the flexibility of MAC vector system.
The stability of 10MAC vectors in cells and tissues of other species remains to be evaluated. As with 11MAC vectors, 10MAC vectors are presumably stable in human cell lines such as fibrosarcoma HT1080 and hepatoblastoma HepG219,25. In addition, high stability of the 11MAC vectors in the humanized Tc rat models for pharmacokinetics implies the potential of 10MAC vectors for generation of Tc rat models8. Establishment of 10MAC-containing cell lines derived from several species may promote investigation on the compatibility between mouse centromere and centromere-associated proteins of host species to search the key factors for chromosome stability. Interestingly, on stability of human chromosomes in the mouse cell line, while human chromosomes 2 and 11 were unstable in the mouse ES cells, HAC derived from human chromosome 14 (SC20) was stable when compared with those chromosomes leading to the concept of the link between the stability and composition of centromeres even in interspecies comparability31. Since the study cannot exclude the effect of endogenous genes of intact or partially fragmented chromosomes on stability, constructions of mammalian ACs without endogenous genes may also promote such analyses.
In conclusion, although universal mammalian AC vector, which is highly stable among the species, is still desired and certain chromosomal vectors such as 11MAC is known to be available for mouse and rat, this study further provided the evidence supporting the original conception that construction of artificial chromosomes from own species is also reasonable strategy for generation of Tc animals from desired species. Collectively, the 10MAC vectors constructed in this study is expected to contribute to generation of Tc mouse models and valuable cell resources for biomedical research and development.
Materials and methods
Ethics statement
This study was approved by the Institutional Animal Care and Use Committee of Tottori University and the Recombinant DNA Experiment safety Committee of Tottori University (for performing recombinant DNA experiments). All experiments were carried out in compliance with the ARRIVE guidelines. All methods were carried out in accordance with relevant guidelines and regulations.
Cell culture
The mouse embryonic fibroblasts, mouse A9 cells, and whole cell hybrids were grown in Dulbecco’s modified Eagle’s medium (DMEM; Wako, Tokyo, Japan) supplemented with 10% fetal bovine serum (FBS; Sigma-Aldrich, St. Louis, MO, USA). The DT40 hybrid cells were maintained in Roswell Park Memorial Institute (RPMI) medium 1640 (Wako, Tokyo, Japan) containing 10% FBS, 1% chicken serum (Gibco, ThermoFischer, Waltham, MA, USA), 50 μmol/L 2-mercaptoethanol, and the appropriate antibiotics. The DT40 hybrids containing a single copy of mouse chromosome 10 were produced by MMCT from mouse A9 hybrid cells containing NeoR-tagged mouse chromosome 10 and maintained with 1500 μg/mL G418 (Promega, Madison, WI, USA). The hypoxanthine phosphoribosyltransferase (Hprt)-deficient CHO (JCRB0218) hybrids containing a 10MAC1, 10MAC2 or 10MAC3 were maintained in Ham’s F-12 nutrient mixture (Wako, Tokyo, Japan) containing 10% FBS and 800 μg/mL G418. The parental mouse ES cell line, TT2F, and the microcell hybrid clone, TT2F (10MAC1), were maintained on mitomycin C (Sigma-Aldrich, St. Louis, MO, USA)-treated neomycin-resistant MEFs (Oriental Yeast, Tokyo, Japan) as feeder layers in DMEM with 18% FBS, 1 mM sodium pyruvate (Invitrogen, Carlsbad, CA, USA), 0.1 mM nonessential amino acids (Invitrogen, Carlsbad, CA, USA), 0.1 mM 2-mercaptoehtanol (Sigma-Aldrich, St. Louis, MO, USA), 2 mM l-glutamine (Invitrogen, Carlsbad, CA, USA), and 1,000 units/mL leukemia inhibitory factor (Funakoshi, Tokyo, Japan).
Construction of targeting vectors
The homologous regions on mouse chromosome 10 are described in Fig. 1. For constructing a telomere truncation vector, pBS-TEL/puro_10MAC, annealed sense and antisense EcoRI/AscI/EcoRI oligos were inserted into EcoRI site of pBS-TEL/Puro vector32. Then, a fragment (5.6 kb) of the mouse chromosome 10 region was amplified by PCR with AscI_m10T F2/BamHI_m10T R3 primers, digested with AscI/BamHI and sub-cloned into the AscI/BamHI sites of the pBS-TEL/Puro vector (pBS-TEL/puro_10MAC). The targeting vector, p10MAC1, for introducing EGFP/neo/loxP-3’HPRT was constructed as follows: Two 1.4 kb and 4.4 kb fragments for homologous arms corresponding to the mouse chromosome 10 pericentromeric region were amplified by PCR using the KpnI_m10 LA F/XhoI_m10 LA R primers (2.0 kb) and SalI_m10 RA F/ NotI_m10 RA R primers (4.4 kb), digested with KpnI/XhoI and SalI/NotI, and subcloned into pKO Scrambler V913 backbone vector (Lexicon Genetics, Woodlands, TX, USA). Then, the EGFP/neo/loxP-3’HPRT cassette from pVGNLH14, digested with SalI/AscI, was introduced into XhoI/AscI sites of the vector (p10MAC1). The targeting vector, p10MAC2, for introducing neo/5’HPRT-loxP was constructed as follows: PGKneo and 5’HPRT-loxP fragments were introduced into EcoRI site and AscI/ClaI sites of pKO Scrambler V907 backbone vector (Lexicon Genetics, Woodlands, TX, USA). Then, a 4.4 kb right arm was amplified by PCR using ClaI_m10 RA F/R primers and inserted into ClaI site of the vector (pN5’HLR). A 2.0 kb left arm was amplified by NotI_m10 LA F/SalI_m10 LA R primers and inserted into NotI/SalI sites of pN5’HLR (p10MAC2). The targeting vector, p10MAC3, for introducing EGFP/neo/5’HPRT-loxP was constructed as follows: CAG-EGFP flanked by insulator HS4 was inserted to NotI/SalI sites of pN5’HLR (pN5’HLER). Then, left arm was amplified by NotI_m10 LA F/SalI_m10 LA R primers and a 1.9 kb NotI/PspOMI-digested fragment was introduced to NotI site of the pN5’HLER (p10MAC3). Primer information is available in Supplementary Table S1.
Transfection of DT40 and CHO cells
The DT40 (mChr.10-neo) hybrid cells were transfected by electroporation of 1 × 107 cells with each NotI-linearized plasmid at 25 μF and 550 V in a 4 mm cuvette using a Gene Pulser (Bio-Rad, Hercules, CA). The cells were resuspended in basic growth medium and aliquoted into 96-well flat-bottomed microtiter plates with serial dilution (Becton–Dickinson, Franklin Lakes, NJ). Next day, the cells were resuspended in selective medium with 0.5 μg/ml puromycin or 1.5 mg/ml G418. Approximately fourteen days later, drug-resistant colonies were picked up and expanded for the following analyses. The CHO cells (2 × 106 cells) containing 10MAC1, 10MAC2 or 10MAC3 were transfected with pBS185 (CMV-Cre) and plasmids containing 5’HPRT-loxP (X6.1), loxP-3’HPRT-I-CAG-EGFP-I (X3.1-I-EGFP-I) or loxP-3’HPRT-I-EF1a-tdTomato-I (X3.1-I-tdTomato-I) by using 20 μL of Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacture’s instruction. After 24 h, cells were scaled up, and after 48 h, cultured in the medium containing 1 × HAT (Sigma-Aldrich, St. Louis, MO, USA) for selection. Fourteen days later, drug-resistant colonies were picked up and expanded for further analyses as described below.
MMCT
The 10MAC1, 10MAC2 and 10MAC3 vectors were transferred from the DT40 cells into the CHO hprt−/− cells using MMCT technology2. Briefly, microcells were prepared by centrifugation of DT40 cells attached to flasks (Nalge Nunc, Rochester, NY, USA) coated with poly-l-lysine followed by fusion with 1 × 106 CHO cells using 42% polyethylene glycol 1000 (Wako, Tokyo, Japan). CHO hybrids containing each 10MAC vector were selected with the media containing 800 μg/mL G418 and selected for expansion. CHO cells containing 10MAC1 without and with ecotropic EnvΔR expression were used as donor microcell hybrids in the PEG-MMCT and retro-MMCT as described previously18,33. mES XO ES9 hybrids containing 10MAC1 were selected with the media containing 150 μg/mL G418 and picked for expansion.
Genomic PCR analysis
Genomic DNA was extracted from cell lines using a genomic extraction kit (Gentra Systems, Minneapolis, MN, USA), and PCR was performed as follows. The screening primers for telomere truncation were m10 F6/PuroI, Gm8155 F/R, Iyd F/R and Plekhg1 F/R. The targeting with p10MAC1 was confirmed by using KpnI_m10 LA F/XhoI m10 LA R, m10 F1/EGFP-F and kj neo/m10 R2. The primers for detection of exact targeting with p10MAC2 were m10 F1/10MAC R1 and 10MAC F1/m10 R2. The targeted allele by p10MAC3 was analyzed by using m10 F1/EGFP-R and 10MAC F1/m10 R2. Contamination of DT40 cells after MMCT from DT40 cells to CHO cells were checked by using CENPH Fw/Rv. Contamination of CHO cells after MMCT from CHO cells to mES cells were checked by using Furin F/R. The recombination with Cre/loxP system on each 10MAC vector was detected by TRNS L1/R1. Primer sequences are described in Supplementary Table S1.
Fluorescence in situ hybridization (FISH) analysis
Preparation of metaphase chromosomes from exponentially growing cell culture was performed according to standard methods. FISH analyses were performed using the digoxigenin-labeled (Roche, Basel, Switzerland) mouse COT-1 DNA (Invitrogen, Carlsbad, CA, USA) or mouse minor satellite DNA, the biotin-labeled PGKpuro, pVGNLH1, X6.1, X3.1-I-EGFP-I, or X3.1-I-tdTomato-I plasmid DNA essentially as described previously33. Chromosomal DNA was counterstained with DAPI (Sigma-Aldrich, St. Louis, MO, US). Images were captured using an AxioImagerZ2 fluorescence microscope (Carl Zeiss, Oberkochen, Germany).
Generation of chimeric mice
Chimeric mice were produced from TT2F hybrids containing 10MAC1. Chimera production was performed as described previously33. mES cells were injected into 8-cell stage embryos derived from ICR mice (CLEA, Tokyo, Japan) and then transferred into pseudopregnant ICR females. Almost 100% coat-color chimeric mice were mated with ICR males to obtain Tc mice.
GFP image capture and FCM analysis of tissues and blood cells
Samples were collected from euthanized Tc mice containing 10MAC1 and their 10MAC1-negative counterpart with isoflurane after perfusion. Bright and GFP images of each tissue were obtained by M205 FA fluorescence stereo microscope (Leica Microsystems, Wetzlar, Germany) with NIS-Elements software (Nikon, Tokyo, Japan). The dissociated cells were treated with ammonium chloride solution for hemolysis and stained with anti-mouse B220/CD45R (Biolegend, San Diego, CA, USA), CD3 (Biolegend, San Diego, CA, USA), CD4 (Biolegend, San Diego, CA, USA) and CD8a (BD Biosciences, San Jose, CA, USA) antibodies conjugated with BV650, BV650, PE and PE-CF594, respectively. All staining samples (1 × 106 cells) were incubated at 4 °C for 30 min in 100 μl FCM buffer (HBSS with 5% FBS and 1 mM EDTA) (Gibco, ThermoFischer, Waltham, MA, USA). DAPI was added to the final suspension to exclude dead cells. Analyses were conducted using a CytoFLEX S (Beckman Coulter, Brea, CA, USA). Percentage of GFP-expressing cells in lymphocytes through generations was analyzed by Gallios (Beckman Coulter, Brea, CA, USA).
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Oshimura, M., Uno, N., Kazuki, Y., Katoh, M. & Inoue, T. A pathway from chromosome transfer to engineering resulting in human and mouse artificial chromosomes for a variety of applications to bio-medical challenges. Chromosome Res. 23, 111–133 (2015).
Kuroiwa, Y. et al. Manipulation of human minichromosomes to carry greater than megabase-sized chromosome inserts. Nat. Biotechnol. 18, 1086–1090 (2000).
Kazuki, Y. et al. Trans-chromosomic mice containing a human CYP3A cluster for prediction of xenobiotic metabolism in humans. Hum. Mol. Genet. 22, 578–592 (2013).
Takiguchi, M. et al. A novel and stable mouse artificial chromosome vector. ACS Synth. Biol. 3, 903–914 (2014).
Takehara, S. et al. A novel transchromosomic system: Stable maintenance of an engineered Mb-sized human genomic fragment translocated to a mouse chromosome terminal region. Transgenic Res. 23, 441–453 (2014).
Yamasaki, Y. et al. Characterization of P-glycoprotein humanized mice generated by chromosome engineering technology: Its utility for prediction of drug distribution to the brain in humans. Drug Metab. Dispos. 46, 1756–1766 (2018).
Abe, S. et al. Modification of single-nucleotide polymorphism in a fully humanized CYP3A mouse by genome editing technology. Sci. Rep. 7, 1–11 (2017).
Kazuki, Y. et al. Humanized UGT2 and CYP3A transchromosomic rats for improved prediction of human drug metabolism. Proc. Natl. Acad. Sci. USA 116, 3072–3081 (2019).
Kazuki, Y. et al. A non-mosaic transchromosomic mouse model of down syndrome carrying the long arm of human chromosome 21. Elife 9, 1–29 (2020).
Moriwaki, T., Abe, S., Oshimura, M. & Kazuki, Y. Transchromosomic technology for genomically humanized animals. Exp. Cell Res. 390, 111914 (2020).
Jaco, I., Canela, A., Vera, E. & Blasco, M. A. Centromere mitotic recombination in mammalian cells. J. Cell Biol. 181, 885–892 (2008).
Arora, U. P., Charlebois, C., Lawal, R. A. & Dumont, B. L. Population and subspecies diversity at mouse centromere satellites. BMC Genomics 22, 1–20 (2021).
Pertile, M. D., Graham, A. N., Choo, K. H. A. & Kalitsis, P. Rapid evolution of mouse Y centromere repeat DNA belies recent sequence stability. Genome Res. 19, 2202–2213 (2009).
Pletcher, M. T. et al. Chromosome evolution: The junction of mammalian chromosomes in the formation of mouse chromosome 10. Genome Res. 10, 1463–1467 (2000).
Gregory, S. G. et al. A physical map of the mouse genome. Nature 418, 743–750 (2002).
Uno, N., Abe, S., Oshimura, M. & Kazuki, Y. Combinations of chromosome transfer and genome editing for the development of cell/animal models of human disease and humanized animal models. J. Hum. Genet. 63, 145–156 (2018).
Suzuki, T., Kazuki, Y., Hara, T. & Oshimura, M. Current advances in microcell-mediated chromosome transfer technology and its applications. Exp. Cell Res. 390, 111915 (2020).
Suzuki, T., Kazuki, Y., Oshimura, M. & Hara, T. Highly efficient transfer of chromosomes to a broad range of target cells using Chinese hamster ovary cells expressing murine leukemia virus-derived envelope proteins. PLoS ONE 11, 1–11 (2016).
Kazuki, K. et al. Highly stable maintenance of a mouse artificial chromosome in human cells and mice. Biochem. Biophys. Res. Commun. 442, 44–50 (2013).
Suzuki, T., Kazuki, Y., Oshimura, M. & Hara, T. A novel system for simultaneous or sequential integration of multiple gene-loading vectors into a defined site of a human artificial chromosome. PLoS ONE 9, 636 (2014).
Yamaguchi, S. et al. A method for producing transgenic cells using a multi-integrase system on a human artificial chromosome vector. PLoS ONE 6, 732 (2011).
Yoshimura, Y. et al. Mouse embryonic stem cells with a multi-integrase mouse artificial chromosome for transchromosomic mouse generation. Transgenic Res. 24, 717–727 (2015).
Honma, K. et al. Development of a multiple-gene-loading method by combining multi-integration system-equipped mouse artificial chromosome vector and CRISPR-Cas9. PLoS ONE 13, 1–19 (2018).
Takenaka, T. et al. Development of Caco-2 cells co-expressing CYP3A4 and NADPH-cytochrome P450 reductase using a human artificial chromosome for the prediction of intestinal extraction ratio of CYP3A4 substrates. Drug Metab. Pharmacokinet. 32, 61–68 (2017).
Satoh, D. et al. Establishment of a novel hepatocyte model that expresses four cytochrome P450 genes stably via mammalian-derived artificial chromosome for pharmacokinetics and toxicity studies. PLoS ONE 12, 1–18 (2017).
Satoh, D. et al. Human and mouse artificial chromosome technologies for studies of pharmacokinetics and toxicokinetics. Drug Metab. Pharmacokinet. 33, 17–30 (2018).
Ohta, Y. et al. Development of Caco-2 cells expressing four CYPs via a mammalian artificial chromosome. BMC Biotechnol. 20, 1–10 (2020).
Kokura, K. et al. A kidney injury molecule-1 (Kim-1) gene reporter in a mouse artificial chromosome: The responsiveness to cisplatin toxicity in immortalized mouse kidney S3 cells. J. Gene Med. 18, 273–281 (2016).
Narai, T. et al. Construction of a luciferase reporter system to monitor osteogenic differentiation of mesenchymal stem cells by using a mammalian artificial chromosome vector. Yonago Acta Med. 58, 23–29 (2015).
Iwado, S., Abe, S., Oshimura, M., Kazuki, Y. & Nakajima, Y. Bioluminescence measurement of time-dependent dynamic changes of cyp-mediated cytotoxicity in cyp-expressing luminescent hepg2 cells. Int. J. Mol. Sci. 22, 1–14 (2021).
Shinohara, T. et al. Stability of transferred human chromosome fragments in cultured cells and in mice. Chromosom. Res. 8, 713–725 (2000).
Kuroiwa, Y. et al. Efficient modification of a human chromosome by telomere-directed truncation in high homologous recombination-proficient chicken DT40 cells. Nucleic Acids Res. 26, 3447–3448 (1998).
Tomizuka, K. et al. Functional expression and germline transmission of a human chromosome fragment in chimaeric mice. Nat. Genet. 16, 133–143 (1997).
Acknowledgements
We thank Toko Kurosaki, Yukako Sumida, Tomoko Ashiba, Kei Yoshida, Eri Kaneda, Masami Morimura, Michika Fukino, Megumi Hirose and Fumihiko Adachi at Tottori University and Wakako Kotoku, Shinya Komoto, Rina Ohnishi, Akane Morita and Moeka Koshima at Trans Chromosomics, Inc. for technical assistance. We also thank Dr. Hiroyuki Kugoh, Dr. Masaharu Hiratsuka, Dr. Hiroyuki Satofuka and Dr. Takahito Ohira at Tottori University for critical discussions. This research was partly performed at the Tottori Bio Frontier managed by Tottori prefecture. The work was supported in part by JST CREST Grant Number JPMJCR18S4, Japan (Y.K.), the Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS) of Japan Agency for Medical Research and Development (AMED) under grant number JP21am0101124 (Y.K.), and the Science and Technology Platform Program for Advanced Biological Medicine from AMED under Grant Number JP21am0401002 (Y.K.).
Author information
Authors and Affiliations
Contributions
S.A. participated in all aspects and wrote the manuscript. K.K. obtained DT40 hybrids with tagged mouse chromosome 10. T.E. constructed vectors. A.O. and H.T. performed chromosome modification. A.O., K.H. and T.S. cultured cells and performed MMCT. K.K. and K.H. performed FISH analyses. K.M. performed generation, maintenance, and analyses of Tc mice. T.M., K.H. and Y.N. performed FCM analyses. S.H. revised the manuscript. S.T., M.O. and Y.K. supervised this study. All authors reviewed the manuscript.
Corresponding author
Ethics declarations
Competing interests
M.O. is a CEO, employee and shareholder of Trans Chromosomics, Inc. S.A., K.H., H.T., T.E., K.M. and S.T. are employees of Trans Chromosomics, Inc., and the other authors declare no conflicts of interest.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Abe, S., Honma, K., Okada, A. et al. Construction of stable mouse artificial chromosome from native mouse chromosome 10 for generation of transchromosomic mice. Sci Rep 11, 20050 (2021). https://doi.org/10.1038/s41598-021-99535-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-021-99535-y
This article is cited by
-
A review of transgenic animal techniques and their applications
Journal of Genetic Engineering and Biotechnology (2023)
-
Full-length human dystrophin on human artificial chromosome compensates for mouse dystrophin deficiency in a Duchenne muscular dystrophy mouse model
Scientific Reports (2023)
-
Nannochloropsis artificial chromosomes (NannoACs) loom on the horizon
Journal of Oceanology and Limnology (2023)
-
Efficient human-like antibody repertoire and hybridoma production in trans-chromosomic mice carrying megabase-sized human immunoglobulin loci
Nature Communications (2022)
-
Simultaneous loading of PCR-based multiple fragments on mouse artificial chromosome vectors in DT40 cell for gene delivery
Scientific Reports (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.